“The release of today’s Institute of Medicine’s report “Countering the Problem of Falsified and Substandard Drugs” calling for a national track and trace system underscores the urgency of Congress taking steps to improve the integrity of our pharmaceutical distribution supply chain for America’s patients. We remain committed to working with our colleagues to enact bipartisan legislation this year to put in place a uniform, national traceability framework built on the principle of advancing workable traceability informed by risk-based circumstances surrounding suspect and illegitimate prescription drugs.”
Pursuant to Senate Policy, petitions, opinion polls, and unsolicited mass electronic communications cannot be initiated by this office for the 60-day period immediately before the date of a primary or general election. Subscribers currently receiving electronic communications from this office who wish to unsubscribe may do so here.
Bennet, Burr React to IOM Report: “Countering the Problem of Falsified and Substandard Drugs”
“The release of today’s Institute of Medicine’s report “Countering the Problem of Falsified and Substandard Drugs” calling for a national track and trace system underscores the urgency of Congress taking steps to improve the integrity of our pharmaceutical distribution supply chain for America’s patients. We remain committed to working with our colleagues to enact bipartisan […]